219 related articles for article (PubMed ID: 2506817)
1. [Intra-arterial chemotherapy of malignant glioma after osmotic blood-brain barrier disruption].
Yamada K; Takahama H; Nakai O; Takanashi T; Hosoya T
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2692-6. PubMed ID: 2506817
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic efficacy of intracarotid infusion of 20% mannitol with ACNU in Fischer rats with intracerebrally implanted 9L gliosarcoma].
Miyagami M; Tazoe M; Kasahara E; Tsubokawa T
Gan To Kagaku Ryoho; 1989 May; 16(5):2059-65. PubMed ID: 2499268
[TBL] [Abstract][Full Text] [Related]
3. [ACNU delivery to malignant glioma tissue by osmotic blood brain barrier modification with intracarotid infusion of hyperosmoral mannitol].
Miyagami M; Kagawa Y; Tsubokawa T
No Shinkei Geka; 1985 Sep; 13(9):955-63. PubMed ID: 2999632
[TBL] [Abstract][Full Text] [Related]
4. [Intra-arterial infusion of high dose methotrexate therapy in recurrent gliomas].
Hayashi A; Kyuma Y
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1461-6. PubMed ID: 2117886
[TBL] [Abstract][Full Text] [Related]
5. [Intra-arterial ACNU, CDDP chemotherapy for brain metastases from lung cancer: comparison of cases with and without intra-arterial mannitol infusion].
Iwadate Y; Namba H; Saegusa T; Sueyoshi K
No Shinkei Geka; 1993 Jun; 21(6):513-8. PubMed ID: 8336809
[TBL] [Abstract][Full Text] [Related]
6. [Reversible opening of the blood-brain barrier in the chemotherapy of malignant gliomas].
Heimberger K; Samec P; Podreka I; Binder H; Suess E; Reisner T; Deecke L; Steger G; Hiesmayr M; Dittrich C
Wien Klin Wochenschr; 1987 May; 99(11):385-8. PubMed ID: 3113082
[TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy with ACNU and radiation therapy in malignant glioma in cerebral hemisphere of adult].
Miyagami M; Tsubokawa T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1447-53. PubMed ID: 2117885
[TBL] [Abstract][Full Text] [Related]
8. Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors.
Neuwelt EA; Hill SA; Frenkel EP; Diehl JT; Maravilla KR; Vu LH; Clark WK; Rapoport SI; Barnett PA; Lewis SE; Ehle AL; Beyer CW
Cancer Treat Rep; 1981; 65 Suppl 2():39-43. PubMed ID: 6809316
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
[TBL] [Abstract][Full Text] [Related]
10. Is intra-arterial chemotherapy useful in high-grade gliomas?
Basso U; Lonardi S; Brandes AA
Expert Rev Anticancer Ther; 2002 Oct; 2(5):507-19. PubMed ID: 12382519
[TBL] [Abstract][Full Text] [Related]
11. Intra-arterial ACNU chemotherapy employing 20% mannitol osmotic blood-brain barrier disruption for malignant brain tumors.
Miyagami M; Tsubokawa T; Tazoe M; Kagawa Y
Neurol Med Chir (Tokyo); 1990 Aug; 30(8):582-90. PubMed ID: 1703636
[TBL] [Abstract][Full Text] [Related]
12. Opening blood-brain-barrier by intracarotid infusion of papaverine in treatment of malignant cerebral glioma.
Xue H; Wang H; Kong L; Zhou H
Chin Med J (Engl); 1998 Aug; 111(8):751-3. PubMed ID: 11245034
[TBL] [Abstract][Full Text] [Related]
13. [Effective measures against side effects by increasing ACNU dose for malignant glioma: effects on digestive organs].
Numa Y; Kasai H; Imahori T; Tsuchida T; Kawamoto K
Gan To Kagaku Ryoho; 1994 Sep; 21(12):2029-33. PubMed ID: 7522001
[TBL] [Abstract][Full Text] [Related]
14. [Treatment results of intra-arterial ACNU infusion chemotherapy for primary cerebral malignant lymphoma].
Hayashi A; Kyuma Y; Chiba Y; Kuwana N; Kojima Y
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1043-7. PubMed ID: 8512332
[TBL] [Abstract][Full Text] [Related]
15. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
[TBL] [Abstract][Full Text] [Related]
16. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.
Fortin D; Desjardins A; Benko A; Niyonsega T; Boudrias M
Cancer; 2005 Jun; 103(12):2606-15. PubMed ID: 15880378
[TBL] [Abstract][Full Text] [Related]
17. Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors.
Neuwelt EA; Rapoport SI
Fed Proc; 1984 Feb; 43(2):214-9. PubMed ID: 6692941
[TBL] [Abstract][Full Text] [Related]
18. [Internal carotid arterial BCNU perfusion in the treatment of cerebral glioma].
Wu ZL
Zhonghua Wai Ke Za Zhi; 1989 Jul; 27(7):421-3, 446. PubMed ID: 2598744
[TBL] [Abstract][Full Text] [Related]
19. In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans.
Siegal T; Rubinstein R; Bokstein F; Schwartz A; Lossos A; Shalom E; Chisin R; Gomori JM
J Neurosurg; 2000 Apr; 92(4):599-605. PubMed ID: 10761648
[TBL] [Abstract][Full Text] [Related]
20. Ocular complication of combined intracarotid chemotherapy and osmotic blood-brain barrier disruption.
Suda K; Nakasu S; Saito A
Nihon Geka Hokan; 1985 Sep; 54(5):359-63. PubMed ID: 3938210
[No Abstract] [Full Text] [Related]
[Next] [New Search]
